Jarrow Formulas Women's Fem-Dophilus® Description
-
Vaginal/Urinary Tract Health
-
No Refrigeration Necessary - New Shelf Stable
-
25+ Years of Research/Clinical Studies
-
Non-GMO
-
Free of Major Allergens
-
Suitable for Vegetarians/Vegans
Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Cruse at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.
GR-1/RC-14 and Vaginal Flora (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
| Amount Per Serving | % Daily Value | |
| Proprietary Probiotic Blend | 134 mg (1 billion CFU) | * |
| Lacticaseibacillus rhamnosus GR-1® | ||
| Limosilactobacillus reuteri RC-14® | ||
